Compare Boeing Co (BA) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boeing Co vs Novavax Inc — how do they compare? Boeing Co trades at $233.4 (market cap $184.35B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Boeing Co is far larger — about 140.7× Novavax Inc's market cap, and Boeing Co pays a 0.03% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| BA | NVAX | |
|---|---|---|
Market Cap | $184.35B | $1.31B |
Volume | 7,591,579 | — |
Sector | Industrials | Health |
52-Week High | $252.15 | $11.19 |
52-Week Low | $179.12 | $6.22 |
Enterprise Value | $210.23B | $889.30M |
Dividend Yield | 0.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boeing Co
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
